Last updated 2026-07-20
- Raised $6M convertible note led by Brainsway, Feb 2026
- Raised $5M convertible note led by Brainsway, Jul 2025
- Raised $4.8M Series A led by KT Squared LLC, May 2017
Total raised
$17.1M
Last: Undisclosed Round 2026-03
Stage
Series A
Founded
2013
Headcount
29
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
Neurolief is a medical technology company developing novel neuromodulation technologies that engage the occipital and trigeminal nerve pathways for major depressive disorder and migraine. The company has developed a non-invasive, multi-channel brain neuromodulation platform designed for both in-home and in-clinic use, enabling precise, focal stimulation of key neural pathways involved in mood and pain regulation. Their flagship therapy, Proliv®Rx, is the first and only FDA-approved prescription neuromodulation therapy for Major Depressive Disorder (MDD) that can be delivered outside traditional clinical settings for patients who have not achieved adequate response to antidepressants. Neurolief is also the developer of Relivion®MG, an FDA-cleared and CE-marked neuromodulation system for the treatment of migraine.
Funding history · 4 rounds · $17.1M total
2026-02
Convertible Debt
$6.0M
★ Brainsway
2025-07
Convertible Debt
$5.0M
★ Brainsway
2017-05
A Round
$4.8M
★ KT Squared LLC★ Champel Capital★ Terra Venture Partners
2014-12
Seed
$1.3M
★ Terralab Ventures★ Terra Venture Partners
Headcount over time
From 11 (2019-01) to 27 (2026-03) · +16 (+145%) · 12 points · source: Finder history + radar grounding
Q&A
- What is Neurolief's primary focus?
- Neurolief develops treatments for patients with chronic neurological and neuropsychiatric disorders, utilizing a digital therapeutics platform of neuromodulation-based solutions.
- What is Neurolief's flagship product?
- Neurolief's flagship product is Relivion, a noninvasive multichannel brain neuromodulation system designed for treating neurological and neuropsychiatric disorders.
- What is the regulatory status of the Relivion system?
- The Relivion system is FDA approved and CE marked, and has also been granted breakthrough device designation by the FDA.
- When was Neurolief founded?
- Neurolief was founded in August 2013.
- How many employees does Neurolief currently have?
- Neurolief has 11-50 employees.
- What was Neurolief's most recent funding round?
- Neurolief closed a funding round in March 2026, with Brainsway as a lead investor.
- What was Neurolief's second most recent funding round?
- Neurolief closed a funding round in August 2025, with Brainsway as a lead investor.
- What is the total amount of funding Neurolief has raised to date?
- Neurolief has raised a total of $17,050,000 USD.
- Which sectors does Neurolief operate in?
- Neurolief operates in Health Tech & Life Sciences, Digital Healthcare, and Digital Therapeutics sectors.
Team · 2
Amit Dar
Founder · Co-Founder & CTO
Shmuel Shany
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Data StorageCloudArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatientsProviders
Business model
B2BB2B2C
Highlights
Verified
Tags
neurologywearablenon-invasivetherapeutic-devicesneuro-stimulationdigital-healthcaremental-healthdoctorspharma-companieshealthcare-providersclinicspatientsmedical-devicesartificial-intelligencedigital-therapeuticstreatmentsmhealthcloudpersonalizationhome-caremobile-applications
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | prolivrx.com |
|---|---|
| linkedin.com/company/11692471 | |
| YouTube | youtube.com/channel/UCLXRI7aEbPOcvFKNtvkmf2Q |
Identifiers & details
| Legal name | Neurolief Inc. |
|---|---|
| Founded | 2013-8 |
| Employees (exact) | 29 |
| Offices | Tampa |
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | prolivrx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514954916 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2013-08-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 5 — shares_capital (2), people (2), other (1) |
| Registered address | גבורי ישראל 12 נתניה |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-25 | הגדלה של הון רשום |
| 2026-05-04 | עדכון דירקטורים-הסרת דירקטור |
| 2026-05-04 | עדכון דירקטורים-הוספת דירקטור |
| 2026-01-04 | הקצאת מניות |
| 2025-09-03 | שינוי בתקנון |